An HTA body must have a defined remit that determines which technologies it will assess. This remit also shapes how the HTA body interacts with stakeholders beyond decision-makers, the level of transparency required, and the involvement of external participants. Its position within a healthcare system influences these factors, as HTA bodies can be part of a health ministry, a quality council, or an independent legally mandated entity.

Below are key considerations for developing a robust HTA process. While not exhaustive, these questions help guide HTA organisations based on their role and stakeholders.

  • How is the HTA body regulated?
  • What is the relationship with government?
  • Are there legal or policy constraints?
  • What technologies require a recommendation by an HTA body?
  • What assessments are required?
  • How are third parties (e.g., patients) involved?
  • What is the level of transparency and accountability?
  • What aspects (domains) are assessed? (e.g., ethical, economic)
  • How are analyses conducted?
  • Is an expert committee required?
  • What is the link to the decision-maker?
  • What are the priorities of the decision-maker?
  • What is the decision-making procedure?
  • What are the decision outputs? (e.g., yes/no)
  • To whom are the recommendations given?
  • In what timeframe?
  • What is the content of communication?
  • How are decisions implemented?
  • What is the result of a recommendation?
  • Who is being impacted?
  • What is a relevant measure of impact?